Clinical Trial Update: Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial comparing peptide-pulsed dendritic cell vaccines with RNA-transfected dendritic cell vaccines in melanoma patients (stage III or IV) has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Peptide-pulsed dendritic cell vaccine (peptide-pulsed dendritic cell vaccine)
• RNA-transfected dendritic cell vaccine (RNA-transfected dendritic cell vaccine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Melanoma Stage III or IV | Phase 1, Phase 2 | Status: COMPLETED